Influenza A Virus Hemagglutinin Activators
The class of Influenza A Virus Hemagglutinin activators, as described above, includes a variety of chemical compounds with distinct mechanisms of action that directly or indirectly modulate the activation of Hemagglutinin during the viral life cycle. While traditionally considered inhibitors due to their antiviral properties, these compounds can be viewed as indirect activators of Hemagglutinin by preventing the downstream consequences of viral replication and spread. Notably, Amantadine, Arbidol, and Zanamivir act on different stages of the viral life cycle, inhibiting M2 ion channels, interfering with viral entry and fusion, and blocking neuraminidase activity, respectively.
Several compounds, including Galidesivir, Favipiravir, and Baloxavir marboxil, inhibit viral RNA synthesis, indirectly influencing Hemagglutinin activation by limiting the production of infectious viral particles. Additionally, Umifenovir, Nitazoxanide, and Oseltamivir disrupt host cell factors critical for viral entry and replication, providing indirect means of modulating Hemagglutinin activation by targeting the early stages of infection. T-705 (Favipiravir) and VX-787 (Pimodivir) specifically target the viral RNA polymerase, interfering with RNA synthesis and limiting the production of new virus particles. In summary, the chemical class of Influenza A Virus Hemagglutinin activators encompasses a diverse array of compounds that, despite their primary role as inhibitors, can be regarded as indirect activators by disrupting key steps in the viral life cycle. These compounds offer specific and targeted approaches to modulate Hemagglutinin activation, providing avenues for research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
1-Adamantylamine | 768-94-5 | sc-251475 sc-251475A | 1 g 25 g | $39.00 $147.00 | ||
1-Adamantylamine acts as an inhibitor of the M2 ion channel, preventing the release of viral genetic material into the host cell. By blocking this viral entry mechanism, Amantadine indirectly modulates the activation of Influenza A Virus Hemagglutinin, providing a targeted approach for influencing the early stages of viral infection. | ||||||
Arbidol Hydrochloride | 131707-23-8 | sc-210834 | 10 mg | $204.00 | ||
Arbidol exhibits antiviral properties by interfering with viral entry and fusion. Its action on the host cell membrane and viral envelope indirectly influences the activation of Influenza A Virus Hemagglutinin, inhibiting the fusion process and preventing viral entry. Arbidol provides an indirect means of modulating Hemagglutinin activation by disrupting key steps in the viral life cycle. | ||||||
Nitazoxanide | 55981-09-4 | sc-212397 | 10 mg | $124.00 | 1 | |
Nitazoxanide exhibits antiviral activity by modulating host cell factors, including the inhibition of hemagglutinin. Its action on host cell factors indirectly influences the activation of Influenza A Virus Hemagglutinin, limiting the spread of the virus. Nitazoxanide provides an indirect means of modulating Hemagglutinin activation by targeting host cell factors critical for viral entry and replication. | ||||||
Peramivir | 330600-85-6 | sc-478569 | 1 mg | $317.00 | ||
Peramivir, a neuraminidase inhibitor, prevents the release of viral particles from infected cells. By blocking neuraminidase activity, Peramivir indirectly influences the activation of Influenza A Virus Hemagglutinin, inhibiting the spread of the virus between host cells. This indirect inhibition occurs by disrupting a critical step in the viral replication cycle. | ||||||
Oseltamivir phosphate | 204255-11-8 | sc-208135 sc-208135A | 10 mg 200 mg | $179.00 $650.00 | 5 | |
Oseltamivir, a neuraminidase inhibitor, prevents the release of viral particles from infected cells. By blocking neuraminidase activity, Oseltamivir indirectly influences the activation of Influenza A Virus Hemagglutinin, inhibiting the spread of the virus between host cells. This indirect inhibition occurs by disrupting a critical step in the viral replication cycle. | ||||||